TrialArthritis & rheumatology (Hoboken, N.J.)2026

A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis.

Kevin D Deane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.